人源与猪源脱细胞真皮基质在胸肌前乳房重建中的表现:长期临床与组织学评估
研究纳入59例连续接受人-猪脱细胞真皮基质(ADM)构建物行组织扩张器/假体乳房重建的患者,平均随访6.7年,最低5年。任何并发症发生率为8.6%。38例患者在置换时获取138份ADM活检标本,组织学分析显示猪源ADM较人源ADM成纤维细胞浸润和血管化更低、炎症反应更高,但无移植物排斥、包膜挛缩或扩张器/假体丢失病例。作者认为猪源ADM临床表现与人源ADM相似,或可作为人源ADM的替代选择。
要点
- 59例患者平均随访6.7年,任何并发症发生率为8.6%。
- 皮肤坏死6.9%、血清肿1.7%、扩张器/假体暴露1.7%、重返手术室2.6%。
- 猪源ADM较人源ADM成纤维细胞浸润和血管化更低、炎症反应更高,但无移植物排斥、包膜挛缩或扩张器/假体丢失。
核心结论
- 猪源ADM临床表现与人源ADM相似,尽管在细胞长入和血管化方面存在微小差异,作者认为其或可作为胸肌前乳房重建中人源ADM的替代选择。
研究设计与样本
- 连续纳入接受人-猪ADM构建物行组织扩张器/假体乳房重建的患者,在置换时获取两种ADM活检标本评估细胞化、血管化和炎症,并从病历中获取术后并发症。
主要发现
- 59例患者符合纳入标准,平均随访6.7年(标准差0.56年),最低随访5年。
- 任何并发症发生率为8.6%,包括皮肤坏死6.9%、血清肿1.7%、扩张器/假体暴露1.7%、重返手术室2.6%。
- 38例患者在扩张器/假体置换时共获取138份ADM活检标本,组织学分析显示猪源ADM较人源ADM成纤维细胞浸润和血管化更低、炎症反应更高,与已发表的非人灵长类结果一致。
- 尽管存在上述差异,无移植物排斥、包膜挛缩或扩张器/假体丢失病例。
临床怎么用
- 作者认为猪源ADM或可作为胸肌前乳房重建中人源ADM的替代选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human acellular dermal matrices (ADMs) remain the most used matrices in prosthetic breast reconstruction. However, the availability and cost of ADMs limit their use in prepectoral reconstruction-which requires large amounts of ADM-and alternative matrices are therefore being explored. OBJECTIVES: The aim of this study was to demonstrate the safety and efficacy of human-porcine ADM constructs via clinical outcomes and histologic evidence of graft integration. METHODS: Consecutive patients undergoing tissue-expander/implant reconstructions with human-porcine ADM constructs were included. Biopsies of both ADMs were obtained at expander/implant exchange and evaluated for cellularization, vascularization, and inflammation. Postoperative complications were retrieved from patient records. RESULTS: Fifty-nine patients met the inclusion criteria. Mean [standard deviation] follow-up was 6.7 [0.56] years; minimum follow-up was 5 years. Any complication rate was 8.6%, including skin necrosis (6.9%), seroma (1.7%), expander/implant exposure (1.7%), and return to the operating room (2.6%). A total of 138 ADM biopsy specimens were obtained from 38 patients at expander/implant exchange. Histologic analyses revealed lower fibroblast infiltration and vascularization and higher inflammatory response in porcine vs human ADM specimens, consistent with published results in nonhuman primates. Despite these differences, there were no cases of graft rejection, capsular contracture, or expander/implant loss. CONCLUSIONS: Porcine ADM performs clinically in a similar manner to human ADM, albeit with minor differences in cellular ingrowth and vascularization, suggesting that it may be an alternative to human ADM in prepectoral breast reconstruction.
引用
- Gabriel A, Maxwell GP, O'Rorke E, et al. Performance of Human and Porcine Derived Acellular Dermal Matrices in Prepectoral Breast Reconstruction: A Long-term Clinicaland Histologic Evaluation. Aesthet Surg J. 2024. PMID: 39344933. doi:10.1093/asj/sjae175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。